The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 15, 2022

Filed:

Jul. 23, 2020
Applicants:

Dennis Keefe, Bedford, MA (US);

Guozhu Zheng, Lexington, MA (US);

Inventors:

Dennis Keefe, Bedford, MA (US);

Guozhu Zheng, Lexington, MA (US);

Vania Broccoli, Monza, IT;

Assignee:

STEALTH BIOTHERAPEUTICS INC., Needham, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4245 (2006.01); A61P 25/28 (2006.01); A61K 31/135 (2006.01); A61K 31/197 (2006.01); A61K 31/4152 (2006.01); A61K 31/4178 (2006.01); A61K 31/4184 (2006.01); A61K 31/5513 (2006.01); A61K 38/30 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4245 (2013.01); A61K 31/135 (2013.01); A61K 31/197 (2013.01); A61K 31/4152 (2013.01); A61K 31/4178 (2013.01); A61K 31/4184 (2013.01); A61K 31/5513 (2013.01); A61K 38/30 (2013.01); A61P 25/28 (2018.01);
Abstract

The present disclosure provides novel methods for treating or preventing amyotrophic lateral sclerosis (ALS), methods for delaying the onset of neurological symptoms associated with ALS, increasing survival in subjects afflicted with ALS, and attenuating the decline of muscle strength associated with ALS in a subject in need thereof. The present disclosure also provides methods for treating or preventing α-synucleinopathy or TDP-43 proteinopathy. The methods comprise administering to the subject an effective amount of a mitochondria-targeting peptidomimetic compound, such as (R)-2-amino-N—((S)-1-(((S)-5-amino-1-(3-benzyl-1,2,4-oxadiazol-5-yl)pentyl)amino)-3-(4-hydroxy-2,6-dimethylphenyl)-1-oxopropan-2-yl)-5-guanidinopentanamide, or a pharmaceutically acceptable salt, stereoisomer, tautomer, hydrate, and/or solvate thereof.


Find Patent Forward Citations

Loading…